Last Posted: Aug 15, 2023
- Childhood cerebral adrenoleukodystrophy (CCALD) in France: epidemiology, natural history, and burden of disease - A population-based study.
Caroline Sevin et al. Orphanet J Rare Dis 2023 18(1) 238 - The impacts of adrenoleukodystrophy newborn screening on the evaluation of adrenal dysfunction in male children: An integrative literature review.
Leslie Pitts et al. J Pediatr Nurs 2023 - Early Detection of Adrenal Insufficiency: The Impact of Newborn Screening for Adrenoleukodystrophy.
Jonanlis Ramirez Alcantara et al. J Clin Endocrinol Metab 2023 - Implementation of Newborn Screening for Conditions in the United States First Recommended during 2010-2018.
Sikha Singh et al. Int J Neonatal Screen 9(2) - Implementation of Newborn Screening for Conditions in the United States First Recommended during 2010–2018
S Singh et al, IJNS, April 2023 - Newborn screening for X-linked adrenoleukodystrophy in Italy: Diagnostic algorithm and disease monitoring.
Eleonora Bonaventura et al. Frontiers in neurology 2023 131072256 - Neurocognitive and mental health impact of adrenoleukodystrophy across the lifespan: Insights for the era of newborn screening.
Pierpont Elizabeth I et al. Journal of inherited metabolic disease 2022 - Parental Depression and Anxiety Associated with Newborn Bloodspot Screening for Rare and Variable-Onset Disorders.
Boychuk Natalie A et al. International journal of neonatal screening 2022 8(4) - Sex-specific newborn screening for X-Linked adrenoleukodystrophy.
Albersen Monique et al. Journal of inherited metabolic disease 2022 - The White Matter Rounds experience: The importance of a multidisciplinary network to accelerate the diagnostic process for adult patients with rare white matter disorders.
Huang Yu Tong et al. Frontiers in neurology 2022 13928493
More
Search Result Summary
- CDC Information (0)
- NIH Information (4)
- CDC Publications (5)
- Hot Topics Archive (8)
- Human Genome Epidemiologic Studies (16)
- GWAS Studies (0)
- Genomics Precision Health (35)
- Non-Genomics Precision Health (0)
- Pathogen Advanced Molecular Detection (0)
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.